ArticleStem cell reviews and reports2026
Creating Engineered NAC Flaps Using in Vivo Revascularization: A Proof-Of-Concept Study.
Article in Stem cell reviews and reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Acellular scaffold revascularization is the most significant challenge in tissue and organ engineering. To achieve successful and durable cell growth within complex three-dimensional scaffolds, a functional vascular network must ensure the supply of oxygen and nutrients within the matrix structure. Several teams have studied in vitro and ex vivo re-endothelialization using dynamic cell seeding and bioreactors, among other techniques. Still, to date, no approach has demonstrated long-term successful and functional vascular tree growth within 3D scaffolds. Herein, we propose a promising alternative using the in vivo implantation of decellularized nipple-areolar complex (NAC) scaffolds on a prepared vascular pedicle, thereby achieving engineered flap creation. We compared two implanted groups, one with and one without vascular micropunctures. After 3 weeks, explanted scaffolds demonstrated successful in-depth capillary growth, supported by contrast angiography, histology (including CD31 staining), and macroscopic bleeding. Flow cytometry assays identified different cell contingents, including CD45 and CD31-positive. No significant difference was found between the two implanted groups. This proof-of-concept study offers valuable insights into the successful engineering of composite tissues and organs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.